Top compounds associated with response to TAGLN3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.26 3e-11
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 3e-11
mRNA manumycin A CTRPv2 pan-cancer AAC 0.21 5e-11
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 2e-10
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.23 5e-10
mRNA FH535 GDSC1000 pan-cancer AAC -0.23 7e-10
mRNA Parthenolide CTRPv2 pan-cancer AAC 0.24 7e-10
mRNA FK866 GDSC1000 pan-cancer AAC 0.2 1e-09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 4e-09
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.41 5e-09
Download CSV